Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation
Tohru Morisada(Keio University), Toshio Suda(Chinese Academy of Sciences), Kari Alitalo(University of Helsinki), Yuichi Oike(Kumamoto University), Hiromitsu Maekawa(University of Helsinki), Yoshiaki Kubota(Keio University), Gou Young Koh(Korea Advanced Institute of Science and Technology), Yoshihiro Yamada(Kagawa University), Shiro Nozawa, Masako Ohmura(University of Helsinki), Takashi Urano(University of Helsinki), Takeshi Miyamoto(Kumamoto Health Science University), Yoshishige Kimura(University of Helsinki), Masaki Akao(University of Helsinki)
Cited by 237
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
|The Journal of Experimental Medicine|2015|2.1k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism
|Nature Medicine|2009|957
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899